Do peroxisome proliferation receptor-γ antagonists have clinical potential as combined antiobesity and antidiabetic drugs?

Doggrell S. (2003) Do peroxisome proliferation receptor-γ antagonists have clinical potential as combined antiobesity and antidiabetic drugs?. Expert Opinion on Investigational Drugs, 12 4: 713-716. doi:10.1517/eoid.12.4.713.23746


Author Doggrell S.
Title Do peroxisome proliferation receptor-γ antagonists have clinical potential as combined antiobesity and antidiabetic drugs?
Journal name Expert Opinion on Investigational Drugs   Check publisher's open access policy
ISSN 1354-3784
Publication date 2003-04-01
Sub-type Critical review of research, literature review, critical commentary
DOI 10.1517/eoid.12.4.713.23746
Volume 12
Issue 4
Start page 713
End page 716
Total pages 4
Subject 3004 Pharmacology
Keyword Diabetes
Mouse models
Obesity
SR-202
Q-Index Code C1
Q-Index Status Provisional Code
Institutional Status Unknown

Document type: Journal Article
Sub-type: Critical review of research, literature review, critical commentary
Collection: Scopus Import
 
Versions
Version Filter Type
Citation counts: Scopus Citation Count Cited 15 times in Scopus Article | Citations
Google Scholar Search Google Scholar
Created: Tue, 28 Jun 2016, 08:09:25 EST by System User